H1B Salary Data

Home › Employers › Pocono Pharmacy Inc

Pocono Pharmacy Inc: H-1B salaries and sponsorship

Pocono Pharmacy Inc filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $114,400.

Applications (LCAs)3
Certified3
Employer addressStroudsburg, PA
H-1B dependent employerNo
Median offered salary$114,400
Middle half of salaries$83,481–$114,400
10th–90th percentile$64,930–$114,400

Does Pocono Pharmacy Inc sponsor H-1B visas?

Pocono Pharmacy Inc filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Nov 7, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Green card (PERM) applications at Pocono Pharmacy Inc: 3 →

Salaries by job title

Job titleLCAsMedian salary
Pharmacist Manager1$114,400
Pharmacy Manager1$114,400
Regulatory & Compliance Analyst1$52,562

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20242$114,400
FY20261$52,562

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Regulatory & Compliance Analyst$52,562
Level I
Stroudsburg, PANov 7, 2025Nov 11, 2025Certified
Pharmacist Manager$114,400
Level II
Stroudsburg, PAMay 13, 2024Oct 24, 2024Certified
Pharmacy Manager$114,400
Level II
Stroudsburg, PAMay 13, 2024Oct 24, 2024Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).